{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:27:49Z","timestamp":1793042869548,"version":"4.5.0"},"reference-count":32,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,18]]},"DOI":"10.61622\/rbgo\/2024rbgo70","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T19:59:30Z","timestamp":1728331170000},"source":"Crossref","is-referenced-by-count":4,"title":["Immunosuppressants in women with repeated implantation failure in assisted reproductive techniques: a systematic review and meta-analysis"],"prefix":"10.61622","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0007-0866","authenticated-orcid":false,"given":"Ana Clara Felix de Farias","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9861-0670","authenticated-orcid":false,"given":"Fernanda Valeriano","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2129-4891","authenticated-orcid":false,"given":"Lubna","family":"Al-Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0308-3481","authenticated-orcid":false,"given":"Kush","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0329-2219","authenticated-orcid":false,"given":"Deyvid Vieira Silva","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9424-6009","authenticated-orcid":false,"given":"Sarah Hasimyan","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2707-9324","authenticated-orcid":false,"given":"Pedro Henrique Costa Matos da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"1","key":"key20241007195928_B1","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-018-0414-2","article-title":"Recurrent implantation failure-update overview on etiology, diagnosis, treatment and future directions","volume":"16","author":"Bashiri","year":"2018","unstructured":"1. Bashiri A, Halper KI, Orvieto R. Recurrent implantation failure-update overview on etiology, diagnosis, treatment and future directions. Reprod Biol Endocrinol. 2018;16(1):121. doi: 10.1186\/s12958-018-0414-2","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"key20241007195928_B2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.fertnstert.2017.04.009","article-title":"Immune modulation treatments-where is the evidence?","volume":"107","author":"Hviid","year":"2017","unstructured":"2. Hviid MM, Macklon N. Immune modulation treatments-where is the evidence? Fertil Steril. 2017;107(6):1284-93. doi: 10.1016\/j.fertnstert.2017.04.009","journal-title":"Fertil Steril"},{"issue":"1","key":"key20241007195928_B3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","unstructured":"3. McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2021;12(1):55-61. doi: 10.1002\/jrsm.1411","journal-title":"Res Syn Meth"},{"key":"key20241007195928_B4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"4. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"key20241007195928_B5","article-title":"Rob 2: a revised tool for assessing the risk of bias in randomized trials","volume":"366","author":"Sterne","year":"2019","unstructured":"5. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. Rob 2: a revised tool for assessing the risk of bias in randomized trials. BMJ. 2019;366:l4898. doi: 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"key20241007195928_B6","first-page":"349","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.3","author":"Page","year":"2022","unstructured":"6. Page MJ, Higgins JP, Sterne JA. Chapter 13: assessing the risk of bias due to missing results in synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, editors. Cochrane handbook for systematic reviews of interventions version 6.3. Hoboken: Wiley; 2022 [cited 2024 Abr 15]. p. 349-74. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-13"},{"issue":"4","key":"key20241007195928_B7","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13525","article-title":"Improved pregnancy outcomes of cyclosporine A on patients with unexplained repeated implantation failure in IVF\/ICSI cycles: a retrospective cohort study","volume":"87","author":"Cheng","year":"2022","unstructured":"7. Cheng W, Wu Y, Wu H, Zou Q, Meng Q, Wang F, et al. Improved pregnancy outcomes of cyclosporine A on patients with unexplained repeated implantation failure in IVF\/ICSI cycles: a retrospective cohort study. Am J Reprod Immunol. 2022;87(4):e13525. doi: 10.1111\/aji.13525","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"key20241007195928_B8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00404-013-3020-8","article-title":"Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure?","volume":"289","author":"Fawzy","year":"2014","unstructured":"8. Fawzy M, El-Refaeey AA. Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure? Arch Gynecol Obstet. 2014;289(3):677-80. doi: 10.1007\/s00404-013-3020-8","journal-title":"Arch Gynecol Obstet"},{"issue":"17","key":"key20241007195928_B9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2023.5302","article-title":"Prednisone vs placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: a randomized clinical trial","volume":"329","author":"Sun","year":"2023","unstructured":"9. Sun Y, Cui L, Lu Y, Tan J, Dong X, Ni T, et al. Prednisone vs placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: a randomized clinical trial. JAMA. 2023;329(17):1460-8. doi: 10.1001\/jama.2023.5302","journal-title":"JAMA"},{"issue":"6","key":"key20241007195928_B10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/humrep\/17.6.1544","article-title":"Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates","volume":"17","author":"Ubaldi","year":"2002","unstructured":"10. Ubaldi F, Rienzi L, Ferrero S, Anniballo R, Iacobelli M, Cobellis L, et al. Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod. 2002;17(6):1544-7. doi: 10.1093\/humrep\/17.6.1544","journal-title":"Hum Reprod"},{"issue":"1","key":"key20241007195928_B11","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-021-00728-x","article-title":"Impacts of cyclosporin A on clinical pregnancy outcomes of patients with a history of unexplained transfer failure: a retrospective cohort study","volume":"19","author":"Qu","year":"2021","unstructured":"11. Qu D, Tian X, Ding L, Li Y, Zhou W. Impacts of cyclosporin A on clinical pregnancy outcomes of patients with a history of unexplained transfer failure: a retrospective cohort study. Reprod Biol Endocrinol. 2021;19(1):44. doi: 10.1186\/s12958-021-00728-x","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"key20241007195928_B12","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s43032-023-01233-9","article-title":"Low molecular weight heparin-aspirin-prednisolone combination does not increase the live birth rate in recurrent implantation failure: a retrospective cohort study","volume":"30","author":"Aslan","year":"2023","unstructured":"12. Aslan K, Kasapoglu I, Cinar C, Cakir C, Avci B, Uncu G. Low molecular weight heparin-aspirin-prednisolone combination does not increase the live birth rate in recurrent implantation failure: a retrospective cohort study. Reprod Sci. 2023;30(11):3253-60. doi: 10.1007\/s43032-023-01233-9","journal-title":"Reprod Sci"},{"issue":"2","key":"key20241007195928_B13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09513590.2017.1380182","article-title":"Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study","volume":"34","author":"Siristatidis","year":"2018","unstructured":"13. Siristatidis C, Dafopoulos K, El-Khayat W, Salamalekis G, Anifandis G, Vrantza T, et al. Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study. Gynecol Endocrinol. 2018;34(2):136-9. doi: 10.1080\/09513590.2017.1380182","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"key20241007195928_B14","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/humrep\/dew186","article-title":"Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise","volume":"31","author":"Robertson","year":"2016","unstructured":"14. Robertson SA, Jin M, Yu D, Moldenhauer LM, Davies MJ, Hull ML, et al. Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise. Hum Reprod. 2016;31(10):2164-73. doi: 10.1093\/humrep\/dew186","journal-title":"Hum Reprod"},{"issue":"1","key":"key20241007195928_B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10815-005-9003-3","article-title":"Does addition of low-dose aspirin and\/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study","volume":"23","author":"Duvan","year":"2006","unstructured":"15. Duvan CI, Ozmen B, Satiroglu H, Atabekoglu CS, Berker B. Does addition of low-dose aspirin and\/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. J Assist Reprod Genet. 2006;23(1):15-21. doi: 10.1007\/s10815-005-9003-3","journal-title":"J Assist Reprod Genet"},{"key":"key20241007195928_B16","volume-title":"StatPearls","author":"Puckett","year":"2023","unstructured":"16. Puckett Y, Gabbar A, Bokhari AA. Prednisone. In: StatPearls. Treasure Island: StatPearls Publishing; 2023 [cited 2024 Abr 12]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534809\/"},{"key":"key20241007195928_B17","volume-title":"StatPearls","author":"Tapia","year":"2023","unstructured":"17. Tapia C, Nessel TA, Zito PM. Cyclosporine. In: StatPearls. Treasure Island: StatPearls Publishing; 2023 [cited 2024 Abr 12]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482450\/"},{"issue":"10","key":"key20241007195928_B18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/oxfordjournals.humrep.a138343","article-title":"Immunosuppression by corticosteroid has no effect on the pregnancy rate in routine in-vitro fertilization\/embryo transfer patients","volume":"9","author":"Lee","year":"1994","unstructured":"18. Lee KA, Koo JJ, Yoon TK, Do BR, Ko JJ, Cha KY. Immunosuppression by corticosteroid has no effect on the pregnancy rate in routine in-vitro fertilization\/embryo transfer patients. Hum Reprod. 1994;9(10):1832-5. doi: 10.1093\/oxfordjournals.humrep.a138343","journal-title":"Hum Reprod"},{"issue":"3","key":"key20241007195928_B19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(16)57428-7","article-title":"Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate","volume":"63","author":"Moffitt","year":"1995","unstructured":"19. Moffitt D, Queenan JT Jr, Veeck LL, Schoolcraft W, Miller CE, Muasher SJ. Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. Fertil Steril. 1995;63(3):571-7. doi: 10.1016\/s0015-0282(16)57428-7","journal-title":"Fertil Steril"},{"issue":"5","key":"key20241007195928_B20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","unstructured":"20. Rubinstein M, Marazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril. 1999;71(5):825-9. doi: 10.1016\/s0015-0282(99)00088-6","journal-title":"Fertil Steril"},{"issue":"4","key":"key20241007195928_B21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.rbmo.2014.12.004","article-title":"Live birth rates after combined adjuvant therapy in IVF-ICSI cycles: a matched case-control study","volume":"30","author":"Motteram","year":"2015","unstructured":"21. Motteram C, Vollenhoven B, Hope N, Osianlis T, Rombauts LJ. Live birth rates after combined adjuvant therapy in IVF-ICSI cycles: a matched case-control study. Reprod Biomed Online. 2015;30(4):340-8. doi: 10.1016\/j.rbmo.2014.12.004","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"key20241007195928_B22","doi-asserted-by":"crossref","first-page":"181S","DOI":"10.1016\/j.transproceed.2004.01.006","article-title":"Optimization of the use of cyclosporine in renal transplantation","volume":"36","author":"Yoshimura","year":"2004","unstructured":"22. Yoshimura N, Okamoto M, Akioka K, Kaihara S. Optimization of the use of cyclosporine in renal transplantation. Transplant Proc. 2004;36(2 Suppl):181S-185S. doi: 10.1016\/j.transproceed.2004.01.006","journal-title":"Transplant Proc"},{"key":"key20241007195928_B23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vetimm.2018.01.003","article-title":"In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs","volume":"197","author":"Archer","year":"2018","unstructured":"23. Archer TM, Stokes JV, Kummari E, Fellman C, Thomason J, Haraschak J, et al. In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs. Vet Immunol Immunopathol. 2018;197:63-8. doi: 10.1016\/j.vetimm.2018.01.003","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"key20241007195928_B24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","unstructured":"24. Paziana K, Del Monaco M, Cardonick E, Moritz M, Keller M, Smith B, et al. Ciclosporin use during pregnancy. Drug Saf. 2013;36(5):279-94. doi: 10.1007\/s40264-013-0034-x","journal-title":"Drug Saf"},{"issue":"8","key":"key20241007195928_B25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","unstructured":"25. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71(8):1051-5. doi: 10.1097\/00007890-200104270-00006","journal-title":"Transplantation"},{"key":"key20241007195928_B26","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2147\/OPTH.S370414","article-title":"Efficacy and safety of 0.1% cyclosporine versus 2% cyclosporine in the treatment of severe vernal keratoconjunctivitis in children","volume":"16","author":"Bourcier","year":"2022","unstructured":"26. Bourcier T, Dory A, Dormegny L, Alcazar J, Gaucher D, Sauer A. Efficacy and safety of 0.1% cyclosporine versus 2% cyclosporine in the treatment of severe vernal keratoconjunctivitis in children. Clin Ophthalmol. 2022;16:3589-96. doi: 10.2147\/OPTH.S370414","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"key20241007195928_B27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.12891\/ceog3375.2017","article-title":"Low dose cyclosporin A treatment increases live birth rate of unexplained recurrent abortion - initial cohort study","volume":"44","author":"Ling","year":"2017","unstructured":"27. Ling Y, Huang Y, Chen C, Mao J, Zhang H. Low dose cyclosporin A treatment increases live birth rate of unexplained recurrent abortion - initial cohort study. Clin Exp Obstet Gynecol. 2017;44(2):230-5.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"6","key":"key20241007195928_B28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.12891\/ceog2006.2015","article-title":"Analysis of the use of cyclosporin A to treat refractory immune recurrent spontaneous abortion","volume":"42","author":"Fu","year":"2015","unstructured":"28. Fu JH. Analysis of the use of cyclosporin A to treat refractory immune recurrent spontaneous abortion. Clin Exp Obstet Gynecol. 2015;42(6):739-42.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"key20241007195928_B29","article-title":"Efficacy of intrauterine perfusion of cyclosporin a for intractable recurrent spontaneous abortion patients with endometrial alloimmune disorders: a randomized controlled trial","volume":"12","author":"Zhao","year":"2021","unstructured":"29. Zhao L, Qi L, Fu J, Bi S, Li L, Fu Y. Efficacy of intrauterine perfusion of cyclosporin a for intractable recurrent spontaneous abortion patients with endometrial alloimmune disorders: a randomized controlled trial. Front Physiol. 2021;12:737878. doi: 10.3389\/fphys.2021.737878","journal-title":"Front Physiol"},{"issue":"4","key":"key20241007195928_B30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","unstructured":"30. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod. 2003;18(4):767-73. doi: 10.1093\/humrep\/deg156","journal-title":"Hum Reprod"},{"issue":"4","key":"key20241007195928_B31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041355","article-title":"Recurrent abortion and the involvement of Killer-Cell Immunoglobulin-like Receptor (KIR) genes, activated T Cells, NK abnormalities, and cytokine profiles","volume":"12","author":"Andreescu","year":"2023","unstructured":"31. Andreescu M, Fr\u00eencu F, Plotogea M, Mehedin?u C. Recurrent abortion and the involvement of Killer-Cell Immunoglobulin-like Receptor (KIR) genes, activated T Cells, NK abnormalities, and cytokine profiles. J Clin Med. 2023;12(4):1355. doi: 10.3390\/jcm12041355","journal-title":"J Clin Med"},{"issue":"10","key":"key20241007195928_B32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1023\/A:1026491426423","article-title":"Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study","volume":"17","author":"Urman","year":"2000","unstructured":"32. Urman B, Mercan R, Alatas C, Balaban B, Isiklar A, Nuhoglu A. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet. 2000;17(10):586-90. doi: 10.1023\/a:1026491426423","journal-title":"J Assist Reprod Genet"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T19:59:38Z","timestamp":1728331178000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/immunosuppressants-in-women-with-repeated-implantation-failure-in-assisted-reproductive-techniques-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":32,"alternative-id":["10.61622\/rbgo\/2024rbgo70"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2024rbgo70","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e-rbgo70"}}